Keros Therapeutics (KROS) Return on Capital Employed [ROCE] (2020 - 2026)
Keros Therapeutics' Return on Capital Employed [ROCE] was -38.39% in Q2 2026, down 38.43 percentage points from 0.04% a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Keros Therapeutics came in at 14.80%, up 60.09 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of +49.88 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -45.29% in FY2024 (+8.82 pp), -54.12% in FY2023 (-10.71 pp), -43.40% in FY2022 (-20.90 pp) and -22.50% in FY2021 (+12.57 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last seven quarters, with an average year-over-year change of +23.62 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2025 (a gain of 49.97 percentage points); the worst was Q2 2026 (a drop of 38.43 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.85 Bn | 1,108.44 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 634.68 Bn | 554.54 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 500.89 Bn | 474.00 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.57 Bn | 308.95 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 300.14 Bn | 264.13 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.91 Bn | 193.31 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 193.96 Bn | 168.15 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 170.07 Bn | 116.71 Bn | 10.94 Bn | 11.86% |
| 10 | Keros Therapeutics | 219.39 Mn | -1.71 Bn | - | -38.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.39% |
| Dec 31, 2025 | 12.99% |
| Sep 30, 2025 | 6.00% |
| Jun 30, 2025 | 0.04% |
| Mar 31, 2025 | -1.56% |
| Dec 31, 2024 | -36.98% |
| Sep 30, 2024 | -41.80% |
| Jun 30, 2024 | -42.00% |
| Mar 31, 2024 | -43.88% |
| Dec 31, 2023 | -52.49% |
| Sep 30, 2023 | -47.89% |
| Jun 30, 2023 | -39.56% |
| Mar 31, 2023 | -39.23% |
| Dec 31, 2022 | -43.63% |
| Sep 30, 2022 | -38.45% |
| Jun 30, 2022 | -37.09% |
| Mar 31, 2022 | -27.72% |
| Dec 31, 2021 | -24.43% |
| Sep 30, 2021 | -28.71% |
| Jun 30, 2021 | -23.27% |
API Access
Keros Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();